Adherence Barriers to Treatment of Patients with Cardiovascular Diseases: A Qualitative Study

Mozhgan Kalantarzadeh1, Hojatollah Yousefi2,3,4, Mousa Alavi1,4

  • 1Nursing PhD Candidate, Departments of Adult Nursing, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Identifying barriers to treatment adherence in Cardiovascular Diseases (CVD) is crucial. Key challenges include patient readiness, healthcare service gaps, and limited access, impacting long-term patient management.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Effective treatment adherence is critical for managing Cardiovascular Diseases (CVD).
  • Patient-related barriers significantly challenge the achievement of care and treatment goals.
  • Understanding these obstacles is essential for improving patient outcomes.

Purpose of the Study:

  • To identify specific barriers to treatment plan adherence in patients diagnosed with Cardiovascular Diseases.
  • To explore the experiences of patients, family caregivers, and healthcare professionals regarding treatment adherence.
  • To inform strategies for enhancing long-term adherence to CVD treatment.

Main Methods:

  • Qualitative content analysis of data from 35 participants (patients, caregivers, healthcare professionals).
  • Study conducted in Isfahan, Iran, between 2019 and 2020.
  • In-depth, semi-structured interviews until data saturation, analyzed using Graneheim and Landman methodology.

Main Results:

  • Three major themes emerged: 'Patients unreadiness to change', 'gap in healthcare services', and 'limited access to healthcare services'.
  • 'Patients unreadiness to change' encompassed misunderstanding conditions and cultural beliefs.
  • 'Gap in healthcare services' included inadequate support and professional discordance; 'limited access' involved physical and financial constraints.

Conclusions:

  • Findings offer a framework for healthcare professionals to develop targeted preventive strategies.
  • Interventions can reduce disease complications and unhealthy behaviors.
  • Enhanced understanding of barriers can lead to prolonged adherence to CVD treatment recommendations.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
424
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
20
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22